NSE shareholding pattern
Cohance Lifesciences Limited shareholding pattern
As of the Jun 2026 shareholding pattern, filed 2026-06-30, promoters held 57.49%, FIIs 6.5%, and DIIs 20.09% of Cohance Lifesciences Limited (COHANCE). Against the Mar 2026 pattern, FII holding is up 0.91 percentage points (5.59% → 6.5%), DII down 1.7 points (21.79% → 20.09%), and promoter holding unchanged at 57.49%. The table below shows how promoter, FII, DII and public holding has moved quarter by quarter, taken from the NSE shareholding pattern.
Definition
A shareholding pattern is the quarterly breakdown of who owns a listed company, split across promoters, foreign institutional investors (FII), domestic institutional investors (DII), and the public. Indian companies file it every quarter under SEBI listing rules. Source: NSE shareholding pattern.
Cohance Lifesciences Limited shareholding by quarter
| Quarter | Promoter % | FII % | DII % | Public % | Filed |
|---|---|---|---|---|---|
| Jun 2026 | 57.49 | 6.5 | 20.09 | 15.92 | 2026-06-30 |
| Mar 2026 | 57.49 | 5.59 | 21.79 | 15.13 | 2026-03-31 |
| Dec 2025 | 57.49 | 6.01 | 21.57 | 14.93 | 2025-12-31 |
| Sep 2025 | 57.49 | 6.51 | 20.81 | 15.19 | 2025-09-30 |
| Jun 2025 | 66.41 | 7.23 | 11.4 | 14.96 | 2025-06-30 |
Disclosures shown are public regulatory filings. Data may be delayed or incomplete. Smart-money entities may no longer hold positions shown. Not investment advice.
Disclosure overlap on Cohance Lifesciences Limited
9 independent managers9 independent managers disclosed positions in Cohance Lifesciences Limited within the same window (May 4, 2026 – Aug 2, 2026), per filings across sources. Who they are — and each underlying filing — is shown inside Flock.
A count of what was filed, per public regulatory filings. Not investment advice.
Related on Flock
- Smart money moves this filing week (insider trades, bulk deals and stake disclosures from the last 7 days)
- All NSE shareholding patterns (browse every company by name)
- What is a 13F filing? (how the US equivalent disclosure works)
- FII and DII activity, sourced and dated
- Today's NSE and BSE bulk and block deals
- When smart money's filings overlap (multi-entity disclosure overlap, explained)
Frequently asked questions
What is the promoter holding in Cohance Lifesciences Limited?
As of the Jun 2026 shareholding pattern, promoters held 57.49% of Cohance Lifesciences Limited (COHANCE). Figures are taken from the NSE shareholding pattern filing dated 2026-06-30 and may change each quarter. Not investment advice.
What is the FII holding in Cohance Lifesciences Limited?
Foreign institutional investors held 6.5% of Cohance Lifesciences Limited as of the Jun 2026 pattern, versus 5.59% in the Mar 2026 pattern. Source: NSE shareholding pattern, filed 2026-06-30. Not investment advice.
How much did FII holding in Cohance Lifesciences Limited change in the Jun 2026 quarter?
FII holding in Cohance Lifesciences Limited was 5.59% in the Mar 2026 pattern and 6.5% in Jun 2026, a difference of 0.91 percentage points up. Promoter holding was unchanged at 57.49% across the two filings, and both figures are percentages as filed. Source: NSE shareholding pattern, filed 2026-06-30. Not investment advice.
How often is the shareholding pattern updated?
Listed Indian companies disclose their shareholding pattern every quarter under SEBI's listing rules. Flock re-stamps each page when a new quarterly pattern is filed, so the freshness chip reflects the true age of the latest data.
The Smart Money Digest
A free weekly email of notable disclosure activity — every line with its filing date and source link. No advice, just filings. Unsubscribe anytime.